Key blood proteins may help identify obesity‑related health risks
These four proteins—adiponectin, leptin, TNF‑α and FGF21—could serve as reliable biomarkers for clinicians to assess obesity‑related risk, and they give researchers clearer targets for future studies aimed at preventing cardiometabolic disease.
Why it matters
Obesity is linked to chronic low‑grade inflammation, but scientists have not agreed on how the levels of various signalling proteins released by fat tissue—called adipokines—change in people who are overweight. Clarifying these patterns matters because they could point to early warning signs of heart and metabolic disease for the general public.
What the study found
The analysis showed that people with obesity have lower amounts of adiponectin, a protein that normally protects against inflammation, and higher amounts of leptin, tumor necrosis factor‑α (TNF‑α) and fibroblast growth factor 21 (FGF21), proteins that promote inflammation or metabolic stress. In contrast, levels of growth differentiation factor 15 (GDF15) and interleukin‑6 (IL‑6) did not differ significantly between obese and normal‑weight individuals.
What it means for people
These four proteins—adiponectin, leptin, TNF‑α and FGF21—could serve as reliable biomarkers for clinicians to assess obesity‑related risk, and they give researchers clearer targets for future studies aimed at preventing cardiometabolic disease.
Sustainable Development Goals
The work supports Sustainable Development Goal 3 – Good Health and Well‑being – by improving understanding of biological markers that could enable earlier detection and management of obesity‑related conditions, ultimately contributing to healthier populations.
Read the original study
Peer-reviewed, in Obesity Science & Practice (2026).